Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy

S. Merrick, Gregory; Bennett, Abbey; Couture, Travis; M. Butler, Wayne; W. Galbreath, Robert; Adamovich, Edward

doi:10.1097/coc.0000000000000174

Public

Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy

Published in American Journal of Clinical Oncology • Jan 12, 2015

Authors:

Gregory S. Merrick

Abbey Bennett

Travis Couture

Abstract

OBJECTIVES: Previous studies have evaluated whether metformin is associated with prostate cancer incidence and outcomes with conflicting conclusions. In this study, we evaluate the incidence of prostate cancer in diabetic patients treated with and without metformin compared with nondiabetic patients...

Subject

Medicine

Prostate cancer

Metformin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!